Karyopharm Therapeutics (NASDAQ: KPTI)

Karyopharm Therapeutics Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of drugs directed against nuclear transport and related targets for the treatment of cancer and other diseases.

Take a look at the 1-year chart of Karyopharm (NASDAQ: KPTI) with the added notations:

KPTI has a key level of support at $17 (green).  The stock appears to be making its way back down to that level again, and traders could expect some sort of a bounce. However, if the $17 support level were to break, lower prices should follow.

The Tale of the Tape: KPTI has key support at $17. A trader could enter a long position at or around $17 with a stop placed under the level. If the stock were to break below the support, a short position could be entered instead.

Before making any trading decision, decide which side of the trade you believe gives you the highest probability of success. Do you prefer the short side of the market, long side, or do you want to be in the market at all? If you haven’t thought about it, review the overall indices themselves. For example, take a look at the S&P 500. Is it trending higher or lower? Has it recently broken through a key resistance or support level? Making these decisions ahead of time will help you decide which side of the trade you believe gives you the best opportunities.

No matter what your strategy or when you decide to enter, always remember to use protective stops and you’ll be around for the next trade.  Capital preservation is always key!

Good luck!

Christian Tharp, CMT